Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
about
Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical IssuesRisk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational StudiesComparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort studyEffectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention.Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department.Just Missing the Mark: Discharging High-risk Atrial Fibrillation / Flutter without Thromboprophylaxis.Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy
P2860
Q26750767-D67109B1-E811-4814-9C9C-A874D8101CFDQ28078747-951171B3-26D5-4A7C-AED0-03A5C28239B0Q37012525-033F1B87-5F39-449E-A793-DCB18FD4F44CQ37076243-292BFE0A-2F59-4315-BE11-EDE814623D86Q38635568-CEE717A0-0D5E-497E-80F8-F8736D226D0CQ39027027-755A6434-88B2-4584-8D42-222371E771D8Q47135358-8E2B735E-24AE-4F0B-9C81-0C187F12397AQ48640243-6EBAEEE1-D3B2-443D-8362-04F4651BB099Q54966103-F4E48437-A3EB-4F59-9E47-FBEF1D3390A2Q55101940-FD9A560A-BBE6-454F-8B25-A2DB8ED9974DQ57817732-E63F40D6-BE8B-48D0-8EAD-844B8091ED4C
P2860
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Choosing a particular oral ant ...... r atrial fibrillation: part 1.
@en
type
label
Choosing a particular oral ant ...... r atrial fibrillation: part 1.
@en
prefLabel
Choosing a particular oral ant ...... r atrial fibrillation: part 1.
@en
P2093
P2860
P50
P356
P1476
Choosing a particular oral ant ...... r atrial fibrillation: part 1.
@en
P2093
Deirdre A Lane
Elaine M Hylek
Freek W A Verheugt
Jack Ansell
James Aisenberg
Michael D Ezekowitz
Roland Veltkamp
Stefan H Hohnloser
P2860
P304
P356
10.1093/EURHEARTJ/EHV643
P50
P577
2017-03-01T00:00:00Z